The Team

ScandiBio Therapeutics is a biotechnology company founded by researchers from the KTH Royal Institute of Technology, Karolinska Institutet and Sahlgrenska Academy in Sweden. The science originates from research conducted at the Science for Life Laboratory in Stockholm (reference Professor Adil Mardinoglu and Professor Mathias Uhlén) together with researchers at the Sahlgrenska Academy in Göteborg (reference Professor Jan Borén). The company has developed a combined metabolic cofactors supplementation (CMCS) aimed to improve for patients with various diseases of metabolic origin.